| Select | Gene | Cds | Cds_length | GC_content | Pep | Pep_length |
|---|---|---|---|---|---|---|
| Vifa1g07509 | ATGCGTTTCTTTCTTCTCTTTTTCTTTCTCTTCCATTTCCGTTTTCAGAACATTCTTTCTTCTCCAATCTCAGAATACCTCGCACTTCTTTCCCTCCGTGAAGCAATTACCGATTCTACCCCTCCTGTTCTCTCTTCATGGAACATCTCAACCACACACTGTATCTGGTTAGGTGTCACATGCGACGCACGCCGTCACGTCACCGGACTCAACCTCACCGGACTCAACCTCTCCGGCACACTCTCCGATAATCTCGCTCATTTCCCGTTTCTCTCTAACCTCTCTTTAGCTGATAACAAATTCTTCGGTCCCATCCCTCCGTCGCTCTCTGCCGTCTCCGGTCTCCGGCTACTCAACCTCTCCAACAATGTCCTCAACGGAACTTTTCCGACCGAGCTTTCGCAACTCAAGAGCCTCGAGATTCTTGACTTGTACAACAACAACATGACCGGAACACTTCCTCTTGCTGTCACCGAGTTGCCGAATCTCCGTCATTTGCATCTCGGTGGTAACTACTTTACCGGCCAGATCCCGCCGGAGTATGGACTATGGCAAAACTTAGAGTATTTAGCTGTTTCCGGTAACGAACTAGCCGGAACTATCCCGCCGGAGATTGGGAACTTAACCAGTCTCCGTGAGCTTTACATCGGATATTTCAATACCTACAACGGTGGCATTCCTCCGGAGATTGGAAACTTAACGGAGCTTATCCGTCTCGACGCAGCTTACTGCGGTTTATCCGGCGAGATACCGCCGGAGATGGGGAAGCTTCAGAATCTAGACACACTATTTCTTCAGGTGAATGCACTTTCAGGTTCTCTTACATGGGAGCTTGGGAATTTGAAAAGCTTGAAATCCATGGATTTGTCTAACAACGTGTTAACCGGTGAGATTCCGACGAGTTTCGGTGAACTGAAGAATCTCACGCTTCTTAACCTTTTTAGAAACAAACTTCACGGTGCTATACCGGAGTTTGTTGGAGATATGCCGGCGTTGGAGGTTGTTCAGCTGTGGGAGAATAACTTCACCGGTAACATACCGATGAGTTTGGGAAGAAACGGAAGGTTAACTCTTCTGGATCTTTCTTCAAACAAGTTAACTGGTACACTTCCACCTTATCTGTGTTCTGGGAATCATCTTCAAACTCTGATAACTCTTGGGAATTTTCTGTTTGGTCCAATTCCTGAATCTCTTGGTACTTGTGAATCTCTGAATAGGATTCGAATGGGTGATAATTTTCTGAATGGTTCGATTCCTAAGGGTCTTTTCGGACTTCCGAAACTAACTCAGGTTGAGCTTCAGGATAATTTTCTATCTGGAAATTTTCCTGAGACTCATTCTGTTTCTGGTAATCTTGGTCAGATTACTCTCTCAAACAATCAGCTTTCTGGACCATTGCCTCCTTCTATTGGTGATTTTTCCAGCATGCAGAAGCTTCTTCTTGATGGTAACATGTTTTCTGGTAAGATTCCGTCGCAGATTGGAAGGTTGCAACAGCTTTCGAAGATTGATTTTAGTCATAACAAGTTTTCTGGTCCTATTGCCCCTGAGATTAGTCAATGCAAGCTTTTAACTTTTGTTGATCTTAGTCGAAATGAGTTATCAGGGGTTATTCCCAATGAGGTTACTGGTATGAGGATATTGAATTACTTCAATATATCTAGAAATCATTTAGTTGGGAGTATTCCTGGTTCTATAGCTTCAATGCAAAGCTTAACTTCTGTTGATTTTTCGTATAACAATCTATCTGGTTTGGTTCCTGGTACCGGTCAATTCAGTTACTTTAACTACACGTCTTTCTTGGGAAATCCTGATCTCTGTGGCCCTTATTTGGGTGCTTGTAAAGACGGTGTTGTGAATGACGCTAATCAATCTCATCACGATAAGGGTCATATTTCTTCTACTGTGAAGCTACTACTTGTTATTGGGTTGCTTGCATGCTCCATTGTGTTTGCTATTGCTGCGATATTCAAGGCTCGGTCTTTGAAGAAGGCGAGTGAGGCCCGTGCGTGGAAATTGACCTCATTTCAACGTTTGGACTTCACTGCTGATGATGTTTTGGTTTCCTTGAAGGAGGATAATATCATAGGAAAGGGAGGTGCTGGCATTGTTTATAAAGGGACAATGCCGAATGGGGAACTTGTTGCTGTTAAAAGGCTTCCGGTTATGAGTAGAGGTTCATCTCATGATCATGGATTCAATGCTGAGATTCAGACATTGGGGAGAATCCGACATAGGCACATTGTTAGGCTGTTGGGTTTCTGTTCAAGTCAGGAGACAAATCTTTTGGTTTACAAGTACATGCCTAATGGAAGTTTAGGTGAAGTTCTTCATGGAAAGAAAGGGGGTCATTTGTATTGGGATACCAGGTATAAAATCGCTGTGGAGGCTGCCAAGGGACTTTGCTATCTACACCATGATTGTTCTCCACTTATTGTTCATCGAGATGTCAAATCAAACAATATACTTCTTGATTCTAATTATGAAGCCCATGTTGCTGATTTTGGGCTGGCTAAGTTCCTGCAAGATTCCGGAACATCCGAATGCATGTCCGCTATTGCTGGTTCATATGGATACATAGCTCCAGAGTACGCGTACACTTTGAAAGTTGATGAGAAAAGCGATGTCTACAGCTTCGGTGTCGTTCTTTTAGAGCTTGTAACTGGAAGGAAACCAGTAGGAGAATTCGGCGACGGTGTGGACATTGTGCAATGGGTGAGAAAAATGACAGACTCCAACAAAGAAGGAGTTCTAAAAGTCCTAGACCCTAGACTTTCATCAGTTCCACTTCATGAAGTCATGCATGTTTTCTATGTAGCCATTCTGTGTGTTGAAGAACAAGCAGTAGAAAGACCAACTATGCGCGAAGTTGTTCAAATTCTGACCGAGCTTCCAAAGTCACCAGAGTCTAAACTAGGAGACTCGACAATTACAGAATCCTCTTTGTCACCATCAAACGGTTTAGAATCTCCAATTTCAGCCTCGAAAGATCATCAACGTCCTCCTCAATCACCACCGCCGGATCTCTTAAGTATTTGA | 3039 | 0.4357 | MRFFLLFFFLFHFRFQNILSSPISEYLALLSLREAITDSTPPVLSSWNISTTHCIWLGVTCDARRHVTGLNLTGLNLSGTLSDNLAHFPFLSNLSLADNKFFGPIPPSLSAVSGLRLLNLSNNVLNGTFPTELSQLKSLEILDLYNNNMTGTLPLAVTELPNLRHLHLGGNYFTGQIPPEYGLWQNLEYLAVSGNELAGTIPPEIGNLTSLRELYIGYFNTYNGGIPPEIGNLTELIRLDAAYCGLSGEIPPEMGKLQNLDTLFLQVNALSGSLTWELGNLKSLKSMDLSNNVLTGEIPTSFGELKNLTLLNLFRNKLHGAIPEFVGDMPALEVVQLWENNFTGNIPMSLGRNGRLTLLDLSSNKLTGTLPPYLCSGNHLQTLITLGNFLFGPIPESLGTCESLNRIRMGDNFLNGSIPKGLFGLPKLTQVELQDNFLSGNFPETHSVSGNLGQITLSNNQLSGPLPPSIGDFSSMQKLLLDGNMFSGKIPSQIGRLQQLSKIDFSHNKFSGPIAPEISQCKLLTFVDLSRNELSGVIPNEVTGMRILNYFNISRNHLVGSIPGSIASMQSLTSVDFSYNNLSGLVPGTGQFSYFNYTSFLGNPDLCGPYLGACKDGVVNDANQSHHDKGHISSTVKLLLVIGLLACSIVFAIAAIFKARSLKKASEARAWKLTSFQRLDFTADDVLVSLKEDNIIGKGGAGIVYKGTMPNGELVAVKRLPVMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSSQETNLLVYKYMPNGSLGEVLHGKKGGHLYWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNYEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELVTGRKPVGEFGDGVDIVQWVRKMTDSNKEGVLKVLDPRLSSVPLHEVMHVFYVAILCVEEQAVERPTMREVVQILTELPKSPESKLGDSTITESSLSPSNGLESPISASKDHQRPPQSPPPDLLSI | 1012 |
| Select | Seq ID | Length | Analysis | Description | Start | End | IPR | GO |
|---|---|---|---|---|---|---|---|---|
| Vifa1g07509 | 1012 | Gene3D | Ribonuclease Inhibitor | 275 | 344 | IPR032675 | - | |
| Vifa1g07509 | 1012 | SUPERFAMILY | Protein kinase-like (PK-like) | 690 | 961 | IPR011009 | - | |
| Vifa1g07509 | 1012 | Gene3D | Ribonuclease Inhibitor | 345 | 618 | IPR032675 | - | |
| Vifa1g07509 | 1012 | FunFam | Leucine-rich repeat receptor-like serine/threonine-protein kinase | 768 | 978 | - | - | |
| Vifa1g07509 | 1012 | FunFam | Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM3 | 333 | 618 | - | - | |
| Vifa1g07509 | 1012 | ProSiteProfiles | Protein kinase domain profile. | 690 | 964 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
| Vifa1g07509 | 1012 | MobiDBLite | consensus disorder prediction | 967 | 1012 | - | - | |
| Vifa1g07509 | 1012 | FunFam | Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM1 | 82 | 325 | - | - | |
| Vifa1g07509 | 1012 | Pfam | Leucine Rich Repeat | 283 | 305 | IPR001611 | GO:0005515 | |
| Vifa1g07509 | 1012 | FunFam | Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM1 | 659 | 767 | - | - | |
| Vifa1g07509 | 1012 | Gene3D | Phosphorylase Kinase; domain 1 | 659 | 767 | - | - | |
| Vifa1g07509 | 1012 | SMART | LRR_typ_2 | 160 | 186 | IPR003591 | - | |
| Vifa1g07509 | 1012 | SMART | LRR_typ_2 | 305 | 329 | IPR003591 | - | |
| Vifa1g07509 | 1012 | SMART | LRR_typ_2 | 497 | 521 | IPR003591 | - | |
| Vifa1g07509 | 1012 | SMART | LRR_typ_2 | 281 | 304 | IPR003591 | - | |
| Vifa1g07509 | 1012 | SMART | LRR_typ_2 | 569 | 592 | IPR003591 | - | |
| Vifa1g07509 | 1012 | SMART | LRR_typ_2 | 354 | 377 | IPR003591 | - | |
| Vifa1g07509 | 1012 | SMART | LRR_typ_2 | 112 | 136 | IPR003591 | - | |
| Vifa1g07509 | 1012 | SMART | serkin_6 | 690 | 938 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
| Vifa1g07509 | 1012 | Gene3D | Transferase(Phosphotransferase) domain 1 | 768 | 980 | - | - | |
| Vifa1g07509 | 1012 | SUPERFAMILY | L domain-like | 349 | 611 | - | - | |
| Vifa1g07509 | 1012 | ProSitePatterns | Serine/Threonine protein kinases active-site signature. | 812 | 824 | IPR008271 | GO:0004672|GO:0006468 | |
| Vifa1g07509 | 1012 | SUPERFAMILY | RNI-like | 69 | 391 | - | - | |
| Vifa1g07509 | 1012 | MobiDBLite | consensus disorder prediction | 969 | 999 | - | - | |
| Vifa1g07509 | 1012 | PANTHER | LRR RECEPTOR-LIKE SERINE/THREONINE-PROTEIN KINASE-RELATED | 222 | 963 | - | - | |
| Vifa1g07509 | 1012 | Pfam | Leucine rich repeat | 114 | 172 | IPR001611 | GO:0005515 | |
| Vifa1g07509 | 1012 | Pfam | Protein tyrosine and serine/threonine kinase | 692 | 961 | IPR001245 | GO:0004672|GO:0006468 | |
| Vifa1g07509 | 1012 | Pfam | Leucine rich repeat N-terminal domain | 24 | 62 | IPR013210 | - | |
| Vifa1g07509 | 1012 | Gene3D | Ribonuclease Inhibitor | 178 | 274 | IPR032675 | - | |
| Vifa1g07509 | 1012 | Gene3D | Ribonuclease Inhibitor | 23 | 177 | IPR032675 | - |
| Select | Gene | Chromosome | Start | End | Duplicated_type |
|---|---|---|---|---|---|
| Vifa1g07509 | Vifa-Chr1 | 1165427485 | 1165430866 | Dispersed/Wgd |
| Select | Gene | Gene_start | Gene_end | Function | Ath_gene | Identity(%) | E-value | Score |
|---|---|---|---|---|---|---|---|---|
| Vifa1g07509 | 12 | 991 | Receptor kinase-like Gene Family | AT5G65700 | 78.766 | 0.0 | 1573 |
| Select | Regulatory Factors | Family | Gene | Hmm_acc | Hmm_name | E_value | Clan |
|---|---|---|---|---|---|---|---|
| PK | RLK-Pelle_LRR-XI-1 | Vifa1g07509 | PK_Tyr_Ser-Thr | 7.8e-45 | CL0016 |
| Select | Query | KO | Definition | Second KO | KEGG Genes ID | GHOSTX Score |
|---|---|---|---|---|---|---|
| Vifa1g07509 | - | - | ccaj:109800149 | 1743.78 |